CA3107910A1 - Sorbant de mxene pour l'elimination de petites molecules d'un dialysat - Google Patents
Sorbant de mxene pour l'elimination de petites molecules d'un dialysat Download PDFInfo
- Publication number
- CA3107910A1 CA3107910A1 CA3107910A CA3107910A CA3107910A1 CA 3107910 A1 CA3107910 A1 CA 3107910A1 CA 3107910 A CA3107910 A CA 3107910A CA 3107910 A CA3107910 A CA 3107910A CA 3107910 A1 CA3107910 A1 CA 3107910A1
- Authority
- CA
- Canada
- Prior art keywords
- urea
- mxene
- aqueous solution
- adsorption
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002594 sorbent Substances 0.000 title description 6
- 150000003384 small molecules Chemical class 0.000 title description 4
- 239000004202 carbamide Substances 0.000 claims abstract description 212
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 211
- 238000000034 method Methods 0.000 claims abstract description 104
- 239000007864 aqueous solution Substances 0.000 claims abstract description 73
- 239000010836 blood and blood product Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 77
- 239000000243 solution Substances 0.000 claims description 46
- 210000002858 crystal cell Anatomy 0.000 claims description 23
- 229910052719 titanium Inorganic materials 0.000 claims description 19
- 150000004767 nitrides Chemical class 0.000 claims description 18
- 229910052758 niobium Inorganic materials 0.000 claims description 14
- -1 VIB metals Chemical class 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 13
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- 150000004703 alkoxides Chemical class 0.000 claims description 12
- 210000003743 erythrocyte Anatomy 0.000 claims description 12
- 229910052715 tantalum Inorganic materials 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 229910052750 molybdenum Inorganic materials 0.000 claims description 11
- 229910052720 vanadium Inorganic materials 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 210000001772 blood platelet Anatomy 0.000 claims description 8
- 229940125691 blood product Drugs 0.000 claims description 8
- 229910052804 chromium Inorganic materials 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 210000000265 leukocyte Anatomy 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 7
- 150000007942 carboxylates Chemical class 0.000 claims description 6
- 150000004820 halides Chemical class 0.000 claims description 6
- 150000004678 hydrides Chemical class 0.000 claims description 6
- 150000003573 thiols Chemical class 0.000 claims description 6
- 210000002381 plasma Anatomy 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 102000004506 Blood Proteins Human genes 0.000 claims description 4
- 108010017384 Blood Proteins Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 229910009819 Ti3C2 Inorganic materials 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000003491 array Methods 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 235000001727 glucose Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 abstract description 11
- 238000005201 scrubbing Methods 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 description 104
- 239000010410 layer Substances 0.000 description 43
- 238000011068 loading method Methods 0.000 description 27
- 239000003463 adsorbent Substances 0.000 description 26
- 239000000463 material Substances 0.000 description 23
- 239000010936 titanium Substances 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 125000004429 atom Chemical group 0.000 description 8
- 238000001631 haemodialysis Methods 0.000 description 8
- 230000000322 hemodialysis Effects 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000008083 Urea Assay Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- MTPVUVINMAGMJL-UHFFFAOYSA-N trimethyl(1,1,2,2,2-pentafluoroethyl)silane Chemical compound C[Si](C)(C)C(F)(F)C(F)(F)F MTPVUVINMAGMJL-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 6
- 238000002615 hemofiltration Methods 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000002156 adsorbate Substances 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 208000020832 chronic kidney disease Diseases 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 229910052723 transition metal Inorganic materials 0.000 description 5
- 238000004166 bioassay Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- ZPZCREMGFMRIRR-UHFFFAOYSA-N molybdenum titanium Chemical compound [Ti].[Mo] ZPZCREMGFMRIRR-UHFFFAOYSA-N 0.000 description 4
- 230000005588 protonation Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 150000003672 ureas Chemical class 0.000 description 4
- BGWLYQZDNFIFRX-UHFFFAOYSA-N 5-[3-[2-[3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propylamino]ethylamino]propyl]-6-phenylphenanthridin-5-ium-3,8-diamine;dichloride Chemical compound [Cl-].[Cl-].C=1C(N)=CC=C(C2=CC=C(N)C=C2[N+]=2CCCNCCNCCC[N+]=3C4=CC(N)=CC=C4C4=CC=C(N)C=C4C=3C=3C=CC=CC=3)C=1C=2C1=CC=CC=C1 BGWLYQZDNFIFRX-UHFFFAOYSA-N 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 208000009852 uremia Diseases 0.000 description 3
- 229910017745 AgNP Inorganic materials 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 229910004472 Ta4C3 Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BVCZEBOGSOYJJT-UHFFFAOYSA-N ammonium carbamate Chemical compound [NH4+].NC([O-])=O BVCZEBOGSOYJJT-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 229910021389 graphene Inorganic materials 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 2
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 2
- APRZHQXAAWPYHS-UHFFFAOYSA-N 4-[5-[3-(carboxymethoxy)phenyl]-3-(4,5-dimethyl-1,3-thiazol-2-yl)tetrazol-3-ium-2-yl]benzenesulfonate Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=C(OCC(O)=O)C=CC=2)=NN1C1=CC=C(S([O-])(=O)=O)C=C1 APRZHQXAAWPYHS-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 238000000719 MTS assay Methods 0.000 description 1
- 231100000070 MTS assay Toxicity 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910003087 TiOx Inorganic materials 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000012909 foetal bovine serum Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000002113 nanodiamond Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- HLLICFJUWSZHRJ-UHFFFAOYSA-N tioxidazole Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)SC2=C1 HLLICFJUWSZHRJ-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000010981 turquoise Substances 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- XJUNLJFOHNHSAR-UHFFFAOYSA-J zirconium(4+);dicarbonate Chemical compound [Zr+4].[O-]C([O-])=O.[O-]C([O-])=O XJUNLJFOHNHSAR-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/0203—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04
- B01J20/0218—Compounds of Cr, Mo, W
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/0203—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04
- B01J20/0211—Compounds of Ti, Zr, Hf
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/0203—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04
- B01J20/0214—Compounds of V, Nb, Ta
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/0203—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04
- B01J20/0274—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04 characterised by the type of anion
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28052—Several layers of identical or different sorbents stacked in a housing, e.g. in a column
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/281—Treatment of water, waste water, or sewage by sorption using inorganic sorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/42—Materials comprising a mixture of inorganic materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/62—In a cartridge
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/38—Organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/002—Construction details of the apparatus
- C02F2201/006—Cartridges
Abstract
La présente invention concerne des procédés pour le lavage de faibles niveaux d'urée dans des solutions aqueuses telles qu'un dialysat provenant d'une dialyse, et comprenant du sang et des produits sanguins, et des dispositifs en mesure d'utiliser ces procédés.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762539715P | 2017-08-01 | 2017-08-01 | |
US62/539,715 | 2017-08-01 | ||
PCT/US2018/041786 WO2019027650A1 (fr) | 2017-08-01 | 2018-07-12 | Sorbant de mxène pour l'élimination de petites molécules d'un dialysat |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3107910A1 true CA3107910A1 (fr) | 2019-02-07 |
Family
ID=65232987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3107910A Pending CA3107910A1 (fr) | 2017-08-01 | 2018-07-12 | Sorbant de mxene pour l'elimination de petites molecules d'un dialysat |
Country Status (4)
Country | Link |
---|---|
US (3) | US11278862B2 (fr) |
EP (1) | EP3661641A4 (fr) |
CA (1) | CA3107910A1 (fr) |
WO (1) | WO2019027650A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220219993A1 (en) * | 2019-05-29 | 2022-07-14 | Nanyang Technological University | Porous nanosheets for effective adsorption of small molecules and volatile organic compounds |
WO2021076236A2 (fr) * | 2019-08-26 | 2021-04-22 | Drexel University | Mxènes pour l'adsorption sélective d'analytes chimiques souhaités et procédé associé |
US20210261415A1 (en) * | 2020-02-20 | 2021-08-26 | Korea Institute Of Science And Technology | Transition metal carbonitride mxene films for emi shielding |
CN111973334A (zh) * | 2020-07-29 | 2020-11-24 | 烯旺新材料科技股份有限公司 | 石墨烯的免疫增强新用途 |
WO2022153889A1 (fr) * | 2021-01-13 | 2022-07-21 | 株式会社村田製作所 | Élément d'adsorption, son procédé de fabrication, feuille d'adsorption, film de séparation et équipement de dialyse artificielle |
CN113209933B (zh) * | 2021-04-15 | 2022-07-01 | 中国工程物理研究院材料研究所 | 一种MXene气凝胶的制备方法及其对磷和铀酰的吸附应用 |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH630745A5 (en) | 1981-01-15 | 1982-06-30 | Jean Felix Orsini | Solar cell and process for manufacturing it |
JPS61113781A (ja) | 1984-11-08 | 1986-05-31 | Tokuyama Soda Co Ltd | 水素発生用陰極 |
JP3423082B2 (ja) | 1994-08-31 | 2003-07-07 | 三洋電機株式会社 | リチウム二次電池 |
JPH10112316A (ja) | 1996-10-08 | 1998-04-28 | Matsushita Electric Ind Co Ltd | 非水電解液二次電池 |
JPH11288715A (ja) | 1998-04-03 | 1999-10-19 | Matsushita Electric Ind Co Ltd | 非水電解質二次電池 |
KR100566183B1 (ko) | 1998-06-09 | 2006-03-29 | 마츠시타 덴끼 산교 가부시키가이샤 | 2차 전지용 음극, 2차 전지용 음극판 및 그것을 이용한 2차 전지 |
US6180049B1 (en) | 1999-06-28 | 2001-01-30 | Nanotek Instruments, Inc. | Layer manufacturing using focused chemical vapor deposition |
US7976941B2 (en) | 1999-08-31 | 2011-07-12 | Momentive Performance Materials Inc. | Boron nitride particles of spherical geometry and process for making thereof |
US6544674B2 (en) | 2000-08-28 | 2003-04-08 | Boston Microsystems, Inc. | Stable electrical contact for silicon carbide devices |
EP1332504A2 (fr) | 2000-11-09 | 2003-08-06 | Foc Frankenburg Oil Company Est. | Supercondensateur et son procede de fabrication |
SE0004203D0 (sv) | 2000-11-16 | 2000-11-16 | Haakan Hugosson | A surface coating |
AU2002307151A1 (en) | 2001-04-06 | 2002-10-21 | Carnegie Mellon University | A process for the preparation of nanostructured materials |
JP4140222B2 (ja) | 2001-04-09 | 2008-08-27 | ソニー株式会社 | 負極、非水電解質二次電池及び負極の製造方法 |
DE10125629A1 (de) | 2001-05-25 | 2002-12-05 | Max Planck Gesellschaft | Siliciumsubnitrid |
US6645612B2 (en) | 2001-08-07 | 2003-11-11 | Saint-Gobain Ceramics & Plastics, Inc. | High solids hBN slurry, hBN paste, spherical hBN powder, and methods of making and using them |
US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
US6872330B2 (en) | 2002-05-30 | 2005-03-29 | The Regents Of The University Of California | Chemical manufacture of nanostructured materials |
US20040048157A1 (en) | 2002-09-11 | 2004-03-11 | Neudecker Bernd J. | Lithium vanadium oxide thin-film battery |
MX268289B (es) | 2002-10-15 | 2009-07-14 | Polyplus Battery Co Inc | Compuestos conductores ionicamente para la proteccion de anodos metalicos activos. |
EP2101556B1 (fr) | 2002-12-27 | 2013-02-13 | FUJIFILM Corporation | Film de blindage électromagnétique transmettant la lumière et panneau d'affichage à plasma utilisant un tel film de blindage |
AU2004257183A1 (en) | 2003-07-03 | 2005-01-27 | Drexel University | Nanoporous carbide derived carbon with tunable pore size |
WO2005038966A1 (fr) | 2003-10-17 | 2005-04-28 | Sanyo Electric Co., Ltd. | Batterie a electrolyte non-aqueux |
JP4781659B2 (ja) | 2003-11-06 | 2011-09-28 | 昭和電工株式会社 | 負極材料用黒鉛粒子、その製造方法及びそれを用いた電池 |
CA2574572A1 (fr) | 2004-07-19 | 2006-10-26 | Baylor College Of Medicine | Modulation des regulateurs de la signalisation des cytokines et applications en immunotherapie |
US7297317B2 (en) | 2004-12-28 | 2007-11-20 | Momentive Performance Materials Inc. | Process for producing boron nitride |
WO2007024556A2 (fr) | 2005-08-19 | 2007-03-01 | Houghton Metal Finishing Company | Procedes et compositions destines au traitement a l'acide d'une surface metallique |
WO2007093011A1 (fr) | 2006-02-17 | 2007-08-23 | Newcastle Innovation Limited | Précurseurs de céramique ternaire cristalline |
DE102006018947A1 (de) | 2006-04-24 | 2007-10-25 | Tutec Gmbh | Verfahren zur Herstellung eines Hartmetallkörpers, Pulver zur Herstellung eines Hartmetalls und Hartmetallkörper |
WO2008073529A2 (fr) | 2006-07-31 | 2008-06-19 | Drexel University | Nanostructures à semi-conducteur intégré et à oxydes métalliques de transition et leurs procédés de préparation |
JP2008078115A (ja) | 2006-08-24 | 2008-04-03 | Nissan Motor Co Ltd | 遷移金属窒化物、燃料電池用セパレータ、遷移金属窒化物の製造方法、燃料電池用セパレータの製造方法、燃料電池スタック、及び燃料電池車両 |
US7527859B2 (en) | 2006-10-08 | 2009-05-05 | Momentive Performance Materials Inc. | Enhanced boron nitride composition and compositions made therewith |
JP2007214137A (ja) | 2007-03-12 | 2007-08-23 | Mitsubishi Chemicals Corp | 非水系炭素被覆リチウム二次電池用負極活物質 |
RU2487197C2 (ru) | 2007-11-16 | 2013-07-10 | Акцо Нобель Н.В. | Электрод |
WO2009091826A2 (fr) | 2008-01-14 | 2009-07-23 | The Board Of Regents Of The University Of Texas System | Compositions et procédés associés à un récepteur d'antigène chimérique spécifique du cd19 humain (h-car) |
KR100877551B1 (ko) | 2008-05-30 | 2009-01-07 | 윤점채 | 전자파 차폐 기능을 갖는 반도체 패키지, 그 제조방법 및 지그 |
WO2010033278A2 (fr) | 2008-06-06 | 2010-03-25 | Dow Global Technologies Inc. | Carbure de titane et de silicium imprégné de métal et corps en carbure de titane et d'aluminium |
EP2228855B1 (fr) | 2009-03-12 | 2014-02-26 | Belenos Clean Power Holding AG | Matériau nano-composite conducteur électriquement poreux ouvert |
US9111658B2 (en) | 2009-04-24 | 2015-08-18 | Applied Nanostructured Solutions, Llc | CNS-shielded wires |
GB0907920D0 (en) | 2009-05-08 | 2009-06-24 | Element Six Production Pty Ltd | Ultra-hard diamond composites |
CN101891141A (zh) | 2009-05-24 | 2010-11-24 | 中国科学院合肥物质科学研究院 | 二维双周期有序结构阵列及其制备方法 |
US20100322909A1 (en) | 2009-06-17 | 2010-12-23 | The University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Th1-associated micrornas and their use for tumor immunotherapy |
US8226801B2 (en) | 2009-07-27 | 2012-07-24 | Nanotek Instruments, Inc. | Mass production of pristine nano graphene materials |
US8303922B2 (en) | 2009-08-24 | 2012-11-06 | The United States Of America As Represeted By The Administrator Of The National Aeronautics And Space Administration | Method for exfoliation of hexagonal boron nitride |
GB201000743D0 (en) | 2010-01-18 | 2010-03-03 | Univ Manchester | Graphene polymer composite |
JP2013542546A (ja) | 2010-03-08 | 2013-11-21 | ウィリアム・マーシュ・ライス・ユニバーシティ | グラフェン/格子混成構造に基づいた透明電極 |
JP5380355B2 (ja) | 2010-04-15 | 2014-01-08 | 信越ポリマー株式会社 | プリント配線板およびその製造方法 |
US20120021224A1 (en) | 2010-07-23 | 2012-01-26 | Clean Energy Labs, Llc | Graphene/graphene oxide platelet composite membranes and methods and devices thereof |
GB201104096D0 (en) | 2011-03-10 | 2011-04-27 | Univ Manchester | Production of graphene |
US9193595B2 (en) | 2011-06-21 | 2015-11-24 | Drexel University | Compositions comprising free-standing two-dimensional nanocrystals |
WO2012177712A1 (fr) | 2011-06-21 | 2012-12-27 | Drexel University | Compositions comprenant des nanocristaux bidimensionnels libres |
ITMI20120191A1 (it) | 2012-02-10 | 2013-08-11 | St Microelectronics Srl | Metodo per trasferire uno strato di grafene |
EP3805186A1 (fr) | 2012-12-04 | 2021-04-14 | Drexel University | Polymere comprenant des nanocristaux bidimensionnels libres |
US20150306570A1 (en) | 2014-04-29 | 2015-10-29 | Ut-Battelle, Llc | Metal-carbon composites and methods for their production |
KR20160149310A (ko) | 2014-05-08 | 2016-12-27 | 록히드 마틴 코포레이션 | 적층된 이차원 소재 및 이를 포함하는 구조체를 제조하는 방법 |
EP3197832B1 (fr) | 2014-09-25 | 2022-06-22 | Drexel University | Formes physiques de matériaux mxene présentant de nouvelles caractéristiques électriques et optiques |
US20180021499A1 (en) | 2015-02-06 | 2018-01-25 | Cabot Corporation | Urea sequestration compositions and methods |
US10720644B2 (en) * | 2015-04-20 | 2020-07-21 | Drexel University | Two-dimensional, ordered, double transition metals carbides having a nominal unit cell composition M′2M″nXn+1 |
TW201723140A (zh) | 2015-12-31 | 2017-07-01 | 安炬科技股份有限公司 | 透明抗靜電膜 |
CN106024416B (zh) | 2016-05-31 | 2018-05-04 | 陕西科技大学 | 氮掺杂棒状的氧化钛/二维层状碳化钛纳米复合电极材料及其制备和应用 |
CN106986316B (zh) | 2017-05-05 | 2019-02-01 | 中国科学院过程工程研究所 | 一种氮化钒材料及其制备方法和应用 |
-
2018
- 2018-07-12 WO PCT/US2018/041786 patent/WO2019027650A1/fr unknown
- 2018-07-12 US US16/633,773 patent/US11278862B2/en active Active
- 2018-07-12 CA CA3107910A patent/CA3107910A1/fr active Pending
- 2018-07-12 EP EP18841636.6A patent/EP3661641A4/fr active Pending
-
2022
- 2022-02-14 US US17/670,716 patent/US11772066B2/en active Active
-
2023
- 2023-07-17 US US18/353,257 patent/US20240017239A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11772066B2 (en) | 2023-10-03 |
US20220161223A1 (en) | 2022-05-26 |
US20240017239A1 (en) | 2024-01-18 |
US20200230569A1 (en) | 2020-07-23 |
WO2019027650A1 (fr) | 2019-02-07 |
EP3661641A4 (fr) | 2021-04-21 |
US11278862B2 (en) | 2022-03-22 |
EP3661641A1 (fr) | 2020-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11772066B2 (en) | MXene sorbent for removal of small molecules from dialysate | |
Meng et al. | MXene sorbents for removal of urea from dialysate: A step toward the wearable artificial kidney | |
Duan et al. | One-pot synthesis of a metal–organic framework-based drug carrier for intelligent glucose-responsive insulin delivery | |
KR20170113624A (ko) | 요소 격리 조성물 및 방법 | |
Wang et al. | Development of versatile metal–organic framework functionalized magnetic graphene core–shell biocomposite for highly specific recognition of glycopeptides | |
CN110269867B (zh) | 用于生物流体净化的组合物 | |
US20220401634A1 (en) | Sorbent for a dialysis device and dialysis system | |
Li et al. | A ratiometric fluorescent hydrogel of controlled thickness prepared continuously using microtomy for the detection and removal of Hg (II) | |
Ye et al. | Hydrogen-bonded biohybrid framework-derived highly specific nanozymes for biomarker sensing | |
Dymek et al. | In search of effective UiO-66 metal–organic frameworks for artificial kidney application | |
WO2011109521A1 (fr) | Hydrogels conjugués de polyamine et d'acide dihydroxybenzoïque utilisés en tant que chélateurs du fer | |
Cuchiaro et al. | Exploring the parameter space of p-Cresyl sulfate adsorption in metal–organic frameworks | |
Klein et al. | Green synthesis of Zr-based metal–organic framework hydrogel composites and their enhanced adsorptive properties | |
Khataei et al. | Applications of porous frameworks in solid‐phase microextraction | |
Bagheri et al. | Recent advances in the application of covalent organic frameworks in extraction: a review | |
EP3950118A1 (fr) | Purificateur de sang | |
Zainol Abidin et al. | Co-adsorptive removal of creatinine and urea by a three-component dual-layer hollow fiber membrane | |
Pu et al. | Hierarchical dendritic mesoporous TiO2 nanocomposites for highly selective enrichment of endogenous phosphopeptides | |
Shashikumar et al. | Trajectory in biological metal-organic frameworks: Biosensing and sustainable strategies-perspectives and challenges | |
Gan et al. | MOFs-alginate/polyacrylic acid/poly (ethylene imine) heparin-mimicking beads as a novel hemoadsorbent for bilirubin removal in vitro and vivo models | |
Chen et al. | Ibuprofen Loaded into Metal–Organic Framework Shells Coated on Fe3O4 Nanoparticles for the Removal of Protein-Bound Uremic Toxins in Blood | |
Cao et al. | Spin-glass behavior of a hierarchically-organized, hybrid microporous material, based on an extended framework of octanuclear iron-oxo units | |
Yang et al. | Preparation of Polyoxometalate-Based Composite by Solidification of Highly Active Cobalt-Containing Polytungstate on Polymeric Ionic Liquid for the Efficient Isolation of Proteinase K | |
Yang et al. | Covalent assembly synthesis of covalent organic framework and MXene based composite for the adsorption of fluoroquinolones | |
US20220339601A1 (en) | METAL-ORGANIC FRAMEWORKS FOR p-Cresyl SULFATE ADSORPTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20220927 |
|
EEER | Examination request |
Effective date: 20220927 |
|
EEER | Examination request |
Effective date: 20220927 |
|
EEER | Examination request |
Effective date: 20220927 |